Cimeio Therapeutics Announces Research Collaboration With the University of Pennsylvania to Conduct Preclinical Studies of a CD45 Universal CAR T Cell Therapy for Patients With Blood and Bone Marrow Cancers

CAMBRIDGE, Mass. & BASEL, Switzerland--(BUSINESS WIRE)--Cimeio Therapeutics today announced a preclinical research collaboration with Saar Gill, M.D., Ph.D., an associate professor of medicine and a researcher in the Center for Cellular Immunotherapies in the Perelman School of Medicine at the University of Pennsylvania, to research and evaluate a novel universal immunotherapy with potential to treat multiple blood and bone marrow cancers. The Penn team will combine Cimeio Therapeutics’ proprie